Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
---|
08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
08/16/2001 | CA2397993A1 Dehydroamino acids |
08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
08/09/2001 | WO2001056979A1 Substituted cyanoacetamide derivatives and herbicides |
08/09/2001 | WO2001056358A2 Enhanced propertied pesticides |
08/09/2001 | WO2001010834A9 Antibacterial agents |
08/09/2001 | WO2000066094A3 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
08/09/2001 | DE10061212A1 Verfahren zur Herstellung heterocyclischer Verbindungen Process for the preparation of heterocyclic compounds |
08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
08/07/2001 | US6271390 Suppression of the IgE-dependent allergic response by benzimidazole analogs |
08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
08/02/2001 | WO2001054481A2 Enhanced propertied pharmaceuticals |
08/02/2001 | CA2397831A1 Enhanced propertied pharmaceuticals |
08/02/2001 | CA2397754A1 Nitrate salts of antimicrobial agents |
08/01/2001 | EP1119568A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
08/01/2001 | CN1305812A N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines |
07/31/2001 | US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
07/31/2001 | US6268312 Oxime derivative and bactericide containing the same as active ingredient |
07/31/2001 | CA2218663C Benzisoxazole and indazole derivatives as antipsychotic agents |
07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
07/26/2001 | CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
07/25/2001 | EP1117639A1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
07/25/2001 | EP0854861B1 Oxyamino oxime ethers, methods and intermediate products for their production, and agents containing them and used for controlling harmful fungi and pests |
07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
07/24/2001 | US6265613 For controlling fungi and pests in plants, seeds, soil, materials |
07/24/2001 | US6265588 Use as pharmaceuticals; as an antigen for production of antibodies and in diagnosis and purification |
07/24/2001 | US6265423 Skin disorders; anticancer agents |
07/24/2001 | US6265400 Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists |
07/24/2001 | CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents |
07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
07/19/2001 | US20010008886 Treatment of corresponding nitrile derivative with hydrogen in the presence of hydrogenation catalyst; thrombolytic agents |
07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
07/18/2001 | EP0636025B1 Compounds useful for treating allergic or inflammatory diseases |
07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
07/17/2001 | US6262098 Estrogen receptor modulators |
07/17/2001 | US6262044 Modulators of protein tyrosine phosphatases (PTPASES) |
07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
07/11/2001 | CN1068316C Process for synthesizing 5-methyl-isoxazole-3-carboxamide |
07/10/2001 | US6258953 Arylacrylamide derivatives |
07/05/2001 | DE19961602A1 3-Nitro-dihydro-isoxazole und -oxazine 3-nitro-dihydro-isoxazole and -oxazines |
07/04/2001 | CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds |
07/03/2001 | US6255327 Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions |
07/03/2001 | US6255326 Antiinflammatory agent; autoimmune diseases |
07/03/2001 | US6255304 Aids therapy |
07/03/2001 | US6255251 Controlling weeds |
06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
06/28/2001 | WO2001046182A1 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazole |
06/28/2001 | WO2001046163A2 3-nitro-dihydro-isoxazoles and oxazines and their use as microbicides |
06/28/2001 | WO2001046152A1 Herbicidal diacyl derivatives of propylene diamine |
06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
06/28/2001 | WO2001010834A3 Antibacterial agents |
06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
06/27/2001 | EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
06/27/2001 | EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides |
06/27/2001 | CN1301246A Process for preparing intermediates |
06/26/2001 | US6252083 Fungicides, insecticides, nematocides |
06/26/2001 | US6251949 Oxime derivatives, hydrazone derivatives and use thereof |
06/26/2001 | US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
06/26/2001 | US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics |
06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
06/21/2001 | WO2001044212A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
06/21/2001 | WO2001044211A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
06/21/2001 | WO2001043742A1 Novel processes for making- and a new crystalline form of- leflunomide |
06/21/2001 | DE19960917A1 Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen New 3-oxo-2,1-benzisoxazol-1 (3H) -carboxamide for the treatment of CNS disorders |
06/21/2001 | CA2397601A1 Novel processes for making- and a new crystalline form of- leflunomide |
06/21/2001 | CA2395167A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
06/21/2001 | CA2387047A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
06/20/2001 | EP1107756A1 Novel isoxazolinone antibacterial agents |
06/20/2001 | CN1300285A Oxyiminoalkanoic acid derivatives |
06/20/2001 | CN1300284A Method for producing isoxazoline-3-yl-acyl benzene |
06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
06/19/2001 | US6248897 From beta-methyl l-aspartate |
06/19/2001 | US6248767 Formulation of sulfonamides for treatment of endothelin-mediated disorders |
06/19/2001 | US6248743 Antithrombotic agents effective to inhibit the production of type 1 plasminogen activator inhibitor (pai-1) |
06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
06/14/2001 | WO2001041762A2 Valdecoxib compositions |
06/14/2001 | WO2001041761A2 Valdecoxib compositions |
06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
06/14/2001 | US20010003752 Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesulfonamide |
06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
06/12/2001 | US6245914 Efficient method for the conversion of nitriles to amidines and species thereof |
06/07/2001 | WO2001040222A1 Substituted isoxazolines and their use as antibacterial agents |
06/07/2001 | WO2001040221A2 Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles as herbicides |